Abbott Agrees to Pay Nearly $385 Million Over Infant Formula Claims
Abbott Laboratories has agreed to pay nearly $385 million to settle allegations that it sold infant formula and nutritional products to government programs while failing to meet federal and state requirements at two of its manufacturing facilities, closing a False Claims Act case built around conditions the Justice Department says exposed products to an unacceptable risk of contamination.
